ArticleVaccine2022

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.

Erin Sparrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.